Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
7,590 total articles
Jefferies analysts say Canadian banks are among the global leaders in adopting artificial intelligence and are beginning to convert those investments into productivity gains that should lift earnings. The firm estimates a 50 to 75 basis point incremental improvement in efficiency over the coming years, with upside of more than 130 basis points not …
Stifel is flagging bond-market volatility as an attractive trade after noting that key volatility gauges and long-duration ETF levels sit near recent lows even after a recent Treasury selloff. The firm points to a widening gap between implied and realized volatility across asset classes, recommends a specific TLT call position for a weakening econo…
Aptevo Therapeutics reported strong interim data for its AML candidate mipletamig used with venetoclax and azacitidine, including an 86% clinical benefit rate and no cases of cytokine release syndrome in frontline patients. Despite these clinical outcomes, Aptevo shares fell 18% on Tuesday, a move the company said may reflect investor unease about …
Citi analysts argue that listed UK water utilities offer more robust protection against inflation for equity holders than energy network companies. The bank points to structural differences in how inflation is allowed to pass through to the Regulatory Asset Base (RAB) for water versus energy networks, and notes persistent uncertainty over how the M…
Futures tied to Canada’s main equity benchmark were muted as markets reacted to fresh statements from U.S. President Donald Trump and escalating military actions across the Middle East. Traders parsed comments suggesting the conflict could broaden, threats to the Strait of Hormuz and evolving developments that sent oil and bond markets swinging bef…
Goldman Sachs data shows short positioning across U.S. macro products - including index and ETF exposures - has climbed to its highest level since September 2022. The bank warns that crowded bearish bets, elevated hedge fund leverage and dealer short gamma create conditions that could produce abrupt market moves, particularly to the upside if negat…
Bank of America has resumed coverage of Qualcomm with an Underperform rating and a $145 price objective, citing subdued revenue and earnings growth through fiscal 2028, the likely loss of Apple modem revenue, and rising in-house semiconductor efforts from major customers. While Qualcomm's moves into automotive, IoT and AI infrastructure offer diver…
European airline stocks advanced after a sharp drop in crude prices following comments by U.S. President Donald Trump that the Iran war would end soon. Data from Morgan Stanley showed notable increases in fares on several long-haul routes and stronger yields in April, while JPMorgan highlighted mixed but potentially offsetting effects for carriers …
TD Cowen cut its recommendation on Novo Nordisk to Hold and lowered the price target to $42, warning that the company faces significant headwinds as semaglutide approaches loss of exclusivity. The bank pointed to disappointing trial results, slower-than-expected Ozempic prescriptions and lingering questions about long-term demand for oral GLP-1 com…
Baird mapped out three potential outcomes for global athletic and retail brand equities as crude oil holds above $100 per barrel on Day 10 of Operation Epic Fury, a U.S.-Iran conflict that began on February 28. The firm weighed a rapid de-escalation, a prolonged high-price environment, and a worst-case recession scenario, and identified a group of …
Macquarie analysts say ongoing conflict in Iran and associated maritime disruptions are creating immediate freight and fuel cost pressures that could weigh on Australian household retailers, particularly furniture sellers. The firm quantifies an immediate negative impact exceeding 2% on fiscal year 2027 net profit after tax if current conditions pe…
Citi Research upgraded Centrica Plc from "neutral" to "buy" and increased its 12-month price target to £2.18 from £2, citing heightened geopolitical risks and rising gas prices as drivers that make government support for strategic energy infrastructure - notably the Rough gas storage facility - more likely. Citi's valuation incorporates potential n…
Barclays analysts say the waste management sector is positioned to absorb rising fuel costs driven by the Iran war through existing surcharge programs and selective pricing levers. Coverage has outperformed the S&P 500 since the conflict began, and firm-level mechanisms differ in speed and scope of pass-through, producing a mixed but generally supp…
Growing use of GLP-1 weight-loss drugs in the U.S. is altering eating habits and taste perception, increasing demand for bold condiments and seasonings. Recent acquisitions of Bachan's and Tapatio illustrate heightened buyer appetite and above-average valuations in the specialty sauce category as buyers position for a long-term shift toward lean pr…
CRISPR Therapeutics AG said it plans a private offering of $350 million in convertible senior notes due 2031, and its stock slid 6.75% on Tuesday. The company will offer the notes to qualified institutional buyers under Rule 144A and may allow initial purchasers to buy up to an additional $52.5 million aggregate principal amount. Key terms such as …
Morgan Stanley analysts say demand for AI computing capacity should continue to exceed available supply as large language model capabilities advance rapidly and the economic case for AI adoption strengthens. The firm identifies value accruing to holders of key infrastructure bottlenecks - labor, power, and premium hardware - while flagging rising o…
MiNK Therapeutics stock climbed sharply after the company announced a collaboration with the C-Further pediatric oncology consortium to develop a PRAME-targeted T cell receptor-engineered invariant natural killer T cell therapy. The agreement supplies about $1.1 million in non-dilutive support for IND-enabling work and includes milestone-linked pay…
Pershing Square USA, the closed-end investment company managed by Pershing Square Capital Management, submitted an IPO registration with the SEC seeking an aggregate offering of at least $5 billion. The planned offering incorporates $2.8 billion in gross commitments from a private placement to be settled alongside the IPO. Shares are planned to be …
UBS upgraded Admiral Group from neutral to buy and increased its 12-month price target to 3,550p, citing a favourable turn in UK motor pricing, stronger-than-expected contribution from non-motor units and a potential one-off capital distribution should an internal Solvency II model be approved. The move lifts EPS estimates and positions shares at a…
U.S. stock-index futures advanced on Tuesday after President Donald Trump said he expects the war in Iran to end soon, easing some immediate market fears. Oil prices, which had spiked on concerns about disruptions through the Strait of Hormuz, reversed course and fell sharply. Investors monitored geopolitical developments, shifts in bond yields and…
Indian equity benchmarks finished higher on Tuesday with the Nifty 50 up 0.97% and the BSE Sensex 30 up 0.82%. Gains in Auto, Consumer Durables and Banking names supported the rally while breadth favored advancers. Volatility declined and commodities showed divergent moves, with gold higher and crude oil down sharply.
Pershing Square USA, Ltd. has filed an SEC registration statement for an initial public offering priced at $50 per share and is pursuing a concurrent private placement, while the prospective parent company has filed its own IPO registration. The combined fundraising is capped at $10 billion in gross proceeds, with all net proceeds directed to the c…
Bill Ackman’s investment firm, Pershing Square, has filed for a U.S. initial public offering on the New York Stock Exchange under the symbol PS. The filing is part of a combined transaction with Pershing Square USA, Ltd. (PSUS), which has secured $2.8 billion in private placement commitments and plans a public offering to bring total proceeds in th…
Grifols shares fell after Morgan Stanley lowered its recommendation to Equal-weight from Overweight and trimmed the price target to €11 from €14, citing reduced visibility on medium-term revenue growth. The bank highlighted pressure in the China albumin market and uncertainty around alpha-1 therapies, while still noting solid profitability and free…
SpaceX is leaning toward an initial public offering on the Nasdaq and is pressing for expedited inclusion in the Nasdaq 100 index as a prerequisite for choosing that exchange. The company is weighing options between Nasdaq and the New York Stock Exchange while exploring mechanisms that would allow newly listed megacaps to join the Nasdaq 100 ahead …
